Uncover key drivers, emerging technologies, and competitive movements shaping the veterinary infectious disease diagnostics market from 2025–2034 with trusted insights from The Business Research Company
How Much Will The Veterinary Infectious Disease Diagnostics Market Be Worth By 2029, And What CAGR Will It Achieve?
The financial dimension of veterinary infectious disease evaluation has seen robust expansion lately, projected to climb from a value of $1.93 billion in 2024 to $2.11 billion in 2025, reflecting an annual compounded growth rate (CAGR) of 8.9%; this upward trajectory during the past period is primarily fueled by a greater number of individuals keeping pets, progress in the field of animal healthcare, the trend of treating pets as family members, and supportive governmental guidelines.
Anticipated for the near future is substantial expansion within the market for veterinary infectious disease diagnostic tools, projecting a rise to a valuation of $3.05 billion by the year 2029, underpinned by a consistent yearly growth rate (CAGR) calculated at 9.7%; this upward trajectory is fueled by several key factors, notably the proliferation of novel diseases, intensified spending on research and development initiatives, the increasing worldwide reach of veterinary medical services, and a continually expanding global population of livestock, while the coming period is characterized by significant shifts such as breakthroughs in technology, swift acceptance of testing methods performed at the patient’s location, the incorporation of advanced molecular diagnostic techniques, the digitization of animal healthcare systems, broadening of commercial offerings, strategic alliances and cooperative agreements forged between entities, and the deployment of diagnostic solutions tailored specifically to various animal breeds.
Access A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6574&type=smp
Which Factors Are Driving The Veterinary Infectious Disease Diagnostics Market Forward?
The burgeoning prevalence of infectious diseases that cross borders and those transferable between animals and humans, exemplified by rabies, is a factor anticipated to boost the expansion of the veterinary diagnostics sector focused on infectious diseases in the future. Diseases transmissible from animals to humans, known as zoonoses, involve the spontaneous passage of illnesses between vertebrate species and people. Veterinary diagnostics for infectious diseases serve the purpose of identifying rabies within domestic pets and other animals, thereby acting as a safeguard against the fatal outcomes that infected animals might cause. As an illustration, data from the World Health Organization (WHO), an intergovernmental body headquartered in Switzerland, indicated in 2022 that rabies was present in more than 150 countries and territories globally. Domestic canines represent the primary vector for human fatalities linked to rabies, responsible for approximately 99 percent of all recorded rabies transmissions. Furthermore, youngsters under fifteen years old constitute a significant portion, accounting for 40 percent of individuals who suffer bites from animals suspected of having rabies. This infection results in the deaths of tens of thousands annually, predominantly affecting populations across Asia and Africa. Consequently, the heightened occurrence of these cross-border and zoonotic illnesses is acting as a catalyst for the advancement of the veterinary infectious disease diagnostics market.
Which Segments Form The Key Structure Of The Veterinary Infectious Disease Diagnostics Market?
The veterinary infectious disease diagnostics market covered in this report is segmented –
1) By Infection Type: Viral Infections, Bacterial Infections, Parasitic Infections, Other Infections
2) By Animal Type: Companion Animal, Food-Producing Animals
3) By Technology: Immunodiagnostics, Molecular Diagnostic, Other Technologies
4) By End User: Reference Laboratories, Veterinary Hospitals And Clinics, Point Of Care, Research Institutes And Universities, Other End Users
Subsegments:
1) By Viral Infections: Canine Parvovirus, Feline Leukemia Virus, Avian Influenza Virus
2) By Bacterial Infections: Canine Bordetella, Leptospirosis, Salmonellosis
3) By Parasitic Infections: Fleas And Ticks, Heartworm, Giardia
4) By Other Infections: Fungal Infections, Mycoplasma Infections
What Strategic Shifts And Innovations Are Influencing The Veterinary Infectious Disease Diagnostics Market?
Progress in technology stands out as the primary burgeoning movement within the veterinary infectious disease diagnostics sector. Leading firms active in this market are continuously debuting novel technological breakthroughs to secure their competitive edge. As one specific illustration, in the month of February 2022, the US entity Merck Animal Health, known for producing animal pharmaceuticals, rolled out SenseHub Feedlot, which utilizes electronic ear tag apparatus. This SenseHub Feedlot system comprises a durable ear tag along with an integrated antenna and an infrared thermistor component capable of gathering, storing, and transmitting data from a receiving station to a central data hub. Fundamentally, SenseHub Feedlot represents a technologically powered system facilitating prompt sickness identification, dependable affliction diagnosis, and the earlier spotting of ailments, thereby enabling superior pain management in bovine populations compared to relying solely on visual assessment.
Which Firms Are Making The Biggest Impact In The Veterinary Infectious Disease Diagnostics Market?
Major companies operating in the veterinary infectious disease diagnostics market include Zoetis Inc., IDEXX Laboratories Inc., Thermo Fisher Scientific Inc., QIAGEN N. V., IDvet, NEOGEN Corporation, INDICAL BIOSCIENCE GmbH, Randox Laboratories Ltd, Creative Diagnostics, Heska Corporation, Chembio Diagnostics Inc., URIT Medical Electronic Co. Ltd., NTBIO Diagnostics Inc., Bio-X Diagnostics, Agrolabo Spa, Virbac, Covetrus Inc., Biomerieux S. A., Bio-Rad Laboratories Inc., Eurofins Scientific SE, Fujifilm Wako Pure Chemical Corporation, GenScript Biotech Corporation, Merck KGaA, MP Biomedicals LLC, Quidel Corporation, Roche Diagnostics Corporation, Siemens Healthineers AG, Sysmex Corporation, VCA Inc., Vetoquinol SA
Download The Full Report Here:
Which Region Is Expected To Lead The Veterinary Infectious Disease Diagnostics Market In The Next Few Years?
North America was the largest region in the veterinary disease diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary infectious disease diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Get A Report Customized For You Here:
https://www.thebusinessresearchcompany.com/customise?id=6574&type=smp
Browse Through More Reports Similar to the Global Veterinary Infectious Disease Diagnostics Market 2025, By The Business Research Company
Veterinary Anti Infectives Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/veterinary-anti-infectives-global-market-report
Animal Antibiotics And Antimicrobials Global Market Report 2025
Veterinary Antibiotics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/veterinary-antibiotics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
